Neurological Outcomes Following Carpal Tunnel Wound-closure Techniques
- Conditions
- Carpal Tunnel Syndrome Bilateral
- Interventions
- Procedure: two-component skin adhesive Glubran Tiss 2®Procedure: skin stitched with transcutaneous nylon suture
- Registration Number
- NCT05808855
- Lead Sponsor
- University of Split, School of Medicine
- Brief Summary
single-centre randomised prospective trial will conducted at the University Hospital of Split in Croatia. The investigators plan to enrol 100 patients, randomly assigned to suture-based wound closure (n=50) or tissue adhesive-based wound closure (n=50) with two-component skin adhesive Glubran Tiss 2®. The neurological outcomes will assessed postoperatively during the follow-up period at intervals of 2, 6, and 12 weeks respectively.
- Detailed Description
All surgical procedures will be performed with a tourniquet and local anaesthesia using 2% lidocaine in the palmar soft tissues and carpal tunnel. For all subjects, the standard carpal canal decompression procedure will began withskin incision in the radial half of the palm, followed by carpal ligament transection and cutting. Following primary closure, two different techniques were used depending on the subject's randomization group:
1. The skin will be stitched with transcutaneous nylon sutures (polypropylene-polyethylene monofilament, non-absorbable surgical suture) 4-0.
2. After subcutaneous stitches with 4-0 Coated VicrylTM Plus PS-2, 3/8 ; a two-component skin adhesive, Glubran Tiss 2® will be applied. Each subject will received 0.35 mL of Glubran Tiss® in the open wound, and before bandaging, subjects rested for 20 seconds for a polymerization process.
The neurological outcomes will assessed postoperatively during the follow-up period at intervals of 2, 6, and 12 weeks respectively.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
(all of the above)
- age >18 years
- carpal tunnel syndrome
- weakness of thumb abduction
- with atrophy of the thenar
- median nerve conduction impairment estimated by electromyography
(one or more)
- threatening haemorrhagic complications (patients with peroral anticoagulation and/or antithrombotic therapy)
- previous wrist trauma or surgery on the wrist region
- another aetiology of neuropathy
- previous allergic reactions (with lidocaine, cyanoacrylate, formaldehyde, tapes, or adhesives)
- personal or family history of keloids or hypertrophic scars
- severe general illness with cachexia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description skin adhesive two-component skin adhesive Glubran Tiss 2® two-component skin adhesive Glubran Tiss 2® suture-based wound closure skin stitched with transcutaneous nylon suture suture-based wound closure
- Primary Outcome Measures
Name Time Method median nerve sensory values measured electromyographic (EMG) 2 months - median nerve sensory action potential (SAP) amplitude (mcV)
- Secondary Outcome Measures
Name Time Method median nerve motoric values measured electromyographic (EMG) 2 months - median nerve motor conduction velocity (m/sec)
Total EMG severity classification 2 months EMG severity will be classified as:
1. Nerve conduction studies normal
2. Minimaly abnormal the median nerve sensory latency (\<3.5 msec)
3. Mild, prolonged median sensory latency (\<3.5 msec),but normal median DML
4. Moderate, prolonged median sensory and DML latencies (\>4.2 msec)
5. Severe, absence of median SAP and prolonged or absent median DML.
Trial Locations
- Locations (2)
Surgery Department, Plastic, Reconstructive and Aesthetic Surgery with Burn Care Division, University Hospital of Split, 21000 Croatia
🇭🇷Split, Croatia
University Hospital of Split, 21000 Croatia
🇭🇷Split, Croatia